Cargando…
Original Hosts, Clinical Features, Transmission Routes, and Vaccine Development for Coronavirus Disease (COVID-19)
The pandemic of coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to public concern worldwide. Although a variety of hypotheses about the hosts of SARS-CoV-2 have been proposed, an exact conclusion has not yet been reached....
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291337/ https://www.ncbi.nlm.nih.gov/pubmed/34295915 http://dx.doi.org/10.3389/fmed.2021.702066 |
_version_ | 1783724615841873920 |
---|---|
author | Wu, Ting Kang, Shuntong Peng, Wenyao Zuo, Chenzhe Zhu, Yuhao Pan, Liangyu Fu, Keyun You, Yaxian Yang, Xinyuan Luo, Xuan Jiang, Liping Deng, Meichun |
author_facet | Wu, Ting Kang, Shuntong Peng, Wenyao Zuo, Chenzhe Zhu, Yuhao Pan, Liangyu Fu, Keyun You, Yaxian Yang, Xinyuan Luo, Xuan Jiang, Liping Deng, Meichun |
author_sort | Wu, Ting |
collection | PubMed |
description | The pandemic of coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to public concern worldwide. Although a variety of hypotheses about the hosts of SARS-CoV-2 have been proposed, an exact conclusion has not yet been reached. Initial clinical manifestations associated with COVID-19 are similar to those of other acute respiratory infections, leading to misdiagnoses and resulting in the outbreak at the early stage. SARS-CoV-2 is predominantly spread by droplet transmission and close contact; the possibilities of fecal–oral, vertical, and aerosol transmission have not yet been fully confirmed or rejected. Besides, COVID-19 cases have been reported within communities, households, and nosocomial settings through contact with confirmed COVID-19 patients or asymptomatic individuals. Environmental contamination is also a major driver for the COVID-19 pandemic. Considering the absence of specific treatment for COVID-19, it is urgent to decrease the risk of transmission and take preventive measures to control the spread of the virus. In this review, we summarize the latest available data on the potential hosts, entry receptors, clinical features, and risk factors of COVID-19 and transmission routes of SARS-CoV-2, and we present the data about development of vaccines. |
format | Online Article Text |
id | pubmed-8291337 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82913372021-07-21 Original Hosts, Clinical Features, Transmission Routes, and Vaccine Development for Coronavirus Disease (COVID-19) Wu, Ting Kang, Shuntong Peng, Wenyao Zuo, Chenzhe Zhu, Yuhao Pan, Liangyu Fu, Keyun You, Yaxian Yang, Xinyuan Luo, Xuan Jiang, Liping Deng, Meichun Front Med (Lausanne) Medicine The pandemic of coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to public concern worldwide. Although a variety of hypotheses about the hosts of SARS-CoV-2 have been proposed, an exact conclusion has not yet been reached. Initial clinical manifestations associated with COVID-19 are similar to those of other acute respiratory infections, leading to misdiagnoses and resulting in the outbreak at the early stage. SARS-CoV-2 is predominantly spread by droplet transmission and close contact; the possibilities of fecal–oral, vertical, and aerosol transmission have not yet been fully confirmed or rejected. Besides, COVID-19 cases have been reported within communities, households, and nosocomial settings through contact with confirmed COVID-19 patients or asymptomatic individuals. Environmental contamination is also a major driver for the COVID-19 pandemic. Considering the absence of specific treatment for COVID-19, it is urgent to decrease the risk of transmission and take preventive measures to control the spread of the virus. In this review, we summarize the latest available data on the potential hosts, entry receptors, clinical features, and risk factors of COVID-19 and transmission routes of SARS-CoV-2, and we present the data about development of vaccines. Frontiers Media S.A. 2021-07-06 /pmc/articles/PMC8291337/ /pubmed/34295915 http://dx.doi.org/10.3389/fmed.2021.702066 Text en Copyright © 2021 Wu, Kang, Peng, Zuo, Zhu, Pan, Fu, You, Yang, Luo, Jiang and Deng. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Wu, Ting Kang, Shuntong Peng, Wenyao Zuo, Chenzhe Zhu, Yuhao Pan, Liangyu Fu, Keyun You, Yaxian Yang, Xinyuan Luo, Xuan Jiang, Liping Deng, Meichun Original Hosts, Clinical Features, Transmission Routes, and Vaccine Development for Coronavirus Disease (COVID-19) |
title | Original Hosts, Clinical Features, Transmission Routes, and Vaccine Development for Coronavirus Disease (COVID-19) |
title_full | Original Hosts, Clinical Features, Transmission Routes, and Vaccine Development for Coronavirus Disease (COVID-19) |
title_fullStr | Original Hosts, Clinical Features, Transmission Routes, and Vaccine Development for Coronavirus Disease (COVID-19) |
title_full_unstemmed | Original Hosts, Clinical Features, Transmission Routes, and Vaccine Development for Coronavirus Disease (COVID-19) |
title_short | Original Hosts, Clinical Features, Transmission Routes, and Vaccine Development for Coronavirus Disease (COVID-19) |
title_sort | original hosts, clinical features, transmission routes, and vaccine development for coronavirus disease (covid-19) |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291337/ https://www.ncbi.nlm.nih.gov/pubmed/34295915 http://dx.doi.org/10.3389/fmed.2021.702066 |
work_keys_str_mv | AT wuting originalhostsclinicalfeaturestransmissionroutesandvaccinedevelopmentforcoronavirusdiseasecovid19 AT kangshuntong originalhostsclinicalfeaturestransmissionroutesandvaccinedevelopmentforcoronavirusdiseasecovid19 AT pengwenyao originalhostsclinicalfeaturestransmissionroutesandvaccinedevelopmentforcoronavirusdiseasecovid19 AT zuochenzhe originalhostsclinicalfeaturestransmissionroutesandvaccinedevelopmentforcoronavirusdiseasecovid19 AT zhuyuhao originalhostsclinicalfeaturestransmissionroutesandvaccinedevelopmentforcoronavirusdiseasecovid19 AT panliangyu originalhostsclinicalfeaturestransmissionroutesandvaccinedevelopmentforcoronavirusdiseasecovid19 AT fukeyun originalhostsclinicalfeaturestransmissionroutesandvaccinedevelopmentforcoronavirusdiseasecovid19 AT youyaxian originalhostsclinicalfeaturestransmissionroutesandvaccinedevelopmentforcoronavirusdiseasecovid19 AT yangxinyuan originalhostsclinicalfeaturestransmissionroutesandvaccinedevelopmentforcoronavirusdiseasecovid19 AT luoxuan originalhostsclinicalfeaturestransmissionroutesandvaccinedevelopmentforcoronavirusdiseasecovid19 AT jiangliping originalhostsclinicalfeaturestransmissionroutesandvaccinedevelopmentforcoronavirusdiseasecovid19 AT dengmeichun originalhostsclinicalfeaturestransmissionroutesandvaccinedevelopmentforcoronavirusdiseasecovid19 |